Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2011, Article ID 325789, 13 pages
http://dx.doi.org/10.1155/2011/325789
Research Article

Ultrastructural Alterations of Myelinated Fibers and Oligodendrocytes in the Prefrontal Cortex in Schizophrenia: A Postmortem Morphometric Study

Laboratory of Clinical Neuropathology, Mental Health Research Center, Zagorodnoe shosse 2, Moscow 117152, Russia

Received 15 January 2011; Revised 7 April 2011; Accepted 24 April 2011

Academic Editor: Haiyun Xu

Copyright © 2011 Natalya A. Uranova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Davis, D. G. Stewart, J. I. Friedman et al., “White matter changes in schizophrenia evidence for myelin-related dysfunction,” Archives of General Psychiatry, vol. 60, no. 5, pp. 443–456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Bartzokis, K. H. Nuechterlein, P. H. Lu, M. Gitlin, S. Rogers, and J. Mintz, “Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study,” Biological Psychiatry, vol. 53, no. 5, pp. 412–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Bartzokis, P. H. Lu, S. B. Stewart et al., “In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia,” Schizophrenia Research, vol. 113, no. 2-3, pp. 322–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kubicki, R. W. McCarley, and M. E. Shenton, “Evidence for white matter abnormalities in schizophrenia,” Current Opinion in Psychiatry, vol. 18, no. 2, pp. 121–134, 2005. View at Google Scholar · View at Scopus
  5. M. Kubicki, R. McCarley, C. F. Westin et al., “A review of diffusion tensor imaging studies in schizophrenia,” Journal of Psychiatric Research, vol. 41, no. 1-2, pp. 15–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Dwork, B. Mancevski, and G. Rosoklija, “White matter and cognitive function in schizophrenia,” International Journal of Neuropsychopharmacology, vol. 10, no. 4, pp. 513–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Höistad, D. Segal, N. Takahashi, T. Sakurai, J. D. Buxbaum, and P. R. Hof, “Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex,” Frontiers in Neuroanatomy, vol. 3, p. 9, 2009. View at Google Scholar
  8. A. Konrad and G. Winterer, “Disturbed structural connectivity in schizophrenia—primary factor in pathology or epiphenomenon?” Schizophrenia Bulletin, vol. 34, no. 1, pp. 72–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Zalesky, A. Fornito, M. L. Seal et al., “Disrupted axonal fiber connectivity in schizophrenia,” Biological Psychiatry, vol. 69, no. 1, pp. 80–89, 2011. View at Google Scholar
  10. M. Walterfang, S. J. Wood, D. Velakoulis, and C. Pantelis, “Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia,” Neuroscience and Biobehavioral Reviews, vol. 30, no. 7, pp. 918–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. S. Buchsbaum, B. R. Buchsbaum, E. A. Hazlett et al., “Relative glucose metabolic rate higher in white matter in patients with schizophrenia,” The American Journal of Psychiatry, vol. 164, no. 7, pp. 1072–1081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. L. Beasley, A. J. Dwork, G. Rosoklija et al., “Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia,” Schizophrenia Research, vol. 109, no. 1–3, pp. 159–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. R. Szeszko, D. G. Robinson, M. Ashtari et al., “Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia,” Neuropsychopharmacology, vol. 33, no. 5, pp. 976–984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. L. R. Skelly, V. Calhoun, S. A. Meda, J. Kim, D. H. Mathalon, and G. D. Pearlson, “Diffusion tensor imaging in schizophrenia: relationship to symptoms,” Schizophrenia Research, vol. 98, no. 1–3, pp. 157–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Wolkin, M. Sanfilipo, A. P. Wolf, B. Angrist, J. D. Brodie, and J. Rotrosen, “Negative symptoms and hypofrontality in chronic schizophrenia,” Archives of General Psychiatry, vol. 49, no. 12, pp. 959–965, 1992. View at Google Scholar · View at Scopus
  16. B. C. Ho, N. C. Andreasen, P. Nopoulos, S. Arndt, V. Magnotta, and M. Flaum, “Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia,” Archives of General Psychiatry, vol. 60, no. 6, pp. 585–594, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. R. Hof, V. Haroutunian, C. Copland, K. L. Davis, and J. D. Buxbaum, “Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia,” Neurochemical Research, vol. 27, no. 10, pp. 1193–1200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. R. Hof, V. Haroutunian, V. L. Friedrich Jr. et al., “Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia,” Biological Psychiatry, vol. 53, no. 12, pp. 1075–1085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. N. A. Uranova, V. M. Vostrikov, D. D. Orlovskaya, and V. I. Rachmanova, “Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium,” Schizophrenia Research, vol. 67, no. 2-3, pp. 269–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. V. M. Vostrikov, N. A. Uranova, and D. D. Orlovskaya, “Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders,” Schizophrenia Research, vol. 94, no. 1–3, pp. 273–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Vostrikov, D. Orlovskaya, and N. Uranova, “Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia,” World Journal of Biological Psychiatry, vol. 9, no. 1, pp. 34–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. V. M. Vostrikov, N. A. Uranova, V. I. Rakhmanova, and D. D. Orlovskaia, “Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia,” Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, vol. 104, no. 1, pp. 47–51, 2004. View at Google Scholar · View at Scopus
  23. L. Marner and B. Pakkenberg, “Total length of nerve fibers in prefrontal and global white matter of chronic schizophrenics,” Journal of Psychiatric Research, vol. 37, no. 6, pp. 539–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Uranova, D. Orlovskaya, O. Vikhreva et al., “Electron microscopy of oligodendroglia in severe mental illness,” Brain Research Bulletin, vol. 55, no. 5, pp. 597–610, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. N. A. Uranova, V. M. Vostrikov, O. V. Vikhreva, I. S. Zimina, N. S. Kolomeets, and D. D. Orlovskaya, “The role of oligodendrocyte pathology in schizophrenia,” International Journal of Neuropsychopharmacology, vol. 10, no. 4, pp. 537–545, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Davis, “Dose equivalence of the antipsychotic drugs,” Journal of Psychiatric Research, vol. 11, pp. 65–69, 1974. View at Google Scholar · View at Scopus
  27. D. Segal, C. Schmitz, and P. R. Hof, “Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia,” Acta Neuropathologica, vol. 117, no. 4, pp. 385–394, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Highley, M. A. Walker, M. M. Esiri, T. J. Crow, and P. J. Harrison, “Asymmetry of the uncinate fasciculus: a post-mortem study of normal subjects and patients with schizophrenia,” Cerebral Cortex, vol. 12, no. 11, pp. 1218–1224, 2002. View at Google Scholar · View at Scopus
  29. S. A. Mitelman, A. M. Brickman, L. Shihabuddin et al., “A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia,” NeuroImage, vol. 37, no. 2, pp. 449–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Mori, T. Ohnishi, R. Hashimoto et al., “Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging,” Psychiatry Research, vol. 154, no. 2, pp. 133–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. L. E. DeLisi, M. Sakuma, W. Tew, M. Kushner, A. L. Hoff, and R. Grimson, “Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia,” Psychiatry Research, vol. 74, no. 3, pp. 129–140, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. J. I. Friedman, C. Tang, D. Carpenter et al., “Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients,” The American Journal of Psychiatry, vol. 165, no. 8, pp. 1024–1032, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. J. Borgwardt, C. Dickey, H. H. Pol, T. J. Whitford, and L. E. DeLisi, “Workshop on defining the significance of progressive brain change in schizophrenia: December 12, 2008 American College of Neuropsychopharmacology (ACNP) all-day satellite, Scottsdale, Arizona. The rapporteurs' report,” Schizophrenia Research, vol. 112, no. 1–3, pp. 32–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Hoptman, J. Volavka, G. Johnson, E. Weiss, R. M. Bilder, and K. O. Lim, “Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study,” Biological Psychiatry, vol. 52, no. 1, pp. 9–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Wolkin, S. J. Choi, S. Szilagyi, M. Sanfilipo, J. P. Rotrosen, and K. O. Lim, “Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study,” The American Journal of Psychiatry, vol. 160, no. 3, pp. 572–574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. M. Bai, K. H. Chou, C. P. Lin et al., “White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study,” Schizophrenia Research, vol. 109, no. 1–3, pp. 167–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C. G. Wible, J. Anderson, M. E. Shenton et al., “Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study,” Psychiatry Research, vol. 108, no. 2, pp. 65–78, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Sanfilipo, T. Lafargue, H. Rusinek et al., “Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms,” Archives of General Psychiatry, vol. 57, no. 5, pp. 471–480, 2000. View at Google Scholar · View at Scopus
  39. B. Kirkpatrick, N. C. Messias, R. R. Conley, and R. C. Roberts, “Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia,” Journal of Nervous and Mental Disease, vol. 191, no. 9, pp. 563–567, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Sanfilipo, T. Lafargue, H. Rusinek et al., “Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms,” Psychiatry Research, vol. 116, no. 1-2, pp. 1–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. D. M. Barch, “The cognitive neuroscience of schizophrenia,” Annual Review of Clinical Psychology, vol. 1, pp. 321–353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. P. Bowley, H. Cabral, D. L. Rosene, and A. Peters, “Age changes in myelinated nerve fibers of the cingulate bundle and corpus callosum in the rhesus monkey,” Journal of Comparative Neurology, vol. 518, no. 15, pp. 3046–3064, 2010. View at Google Scholar
  43. J. H. Sandell and A. Peters, “Effects of age on nerve fibers in the rhesus monkey optic nerve,” Journal of Comparative Neurology, vol. 429, no. 4, pp. 541–553, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Peters and C. Sethares, “Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey,” Journal of Comparative Neurology, vol. 442, no. 3, pp. 277–291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Peters, “The effects of normal aging on myelinated nerve fibers in monkey central nervous system,” Frontiers in Neuroanatomy, vol. 3, p. 11, 2009. View at Google Scholar
  46. J. Luebke, H. Barbas, and A. Peters, “Effects of normal aging on prefrontal area 46 in the rhesus monkey,” Brain Research Reviews, vol. 62, no. 2, pp. 212–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Mitterauer, “The incoherence hypothesis of schizophrenia: based on decomposed oligodendrocyte-axonic relations,” Medical Hypotheses, vol. 69, no. 6, pp. 1299–1304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. N. A. Uranova, D. D. Orlovskaya, I. S. Zimina et al., “Ultrastructural pathology of myelinated fibers in schizophrenia: a morphometric study of prefrontal and visual cortex. Abstracts of the IXth International Congress on Schizophrenia Research,” Schizophrenia Research, vol. 60, no. 1, p. 76, 2003. View at Google Scholar
  49. N. S. Kolomeets and N. A. Uranova, “Pathology of oligodendroglia and myelinated fibers of the hippocampus in schizophrenia (an ultrastructural and morphometric study),” Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, vol. 108, no. 8, pp. 52–60, 2008 (Russian). View at Google Scholar · View at Scopus
  50. N. A. Uranova, D. D. Orlovskaya, and I. S. Zimina, “Decreased synaptic size in schizophrenic cortex: a postmortem morphometric electron microscopic study,” in Proceedings of the 30th Annual Meeting of the Society for Neuroscience, vol. 26, p. 1558, 2000.
  51. N. A. Uranova, O. V. Vikhreva, I. S. Zimina et al., “Abnormal patterns of cortical synaptic connectivity in schizophrenia,” Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, no. 3, pp. 8–14, 2007 (Russian). View at Google Scholar · View at Scopus
  52. V. Haroutunian, P. Katsel, S. Dracheva, D. G. Stewart, and K. L. Davis, “Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia,” International Journal of Neuropsychopharmacology, vol. 10, no. 4, pp. 565–573, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Byun and E. Delpire, “Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice,” Neurobiology of Disease, vol. 28, no. 1, pp. 39–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. K. A. Nave and B. D. Trapp, “Axon-glial signaling and the glial support of axon function,” Annual Review of Neuroscience, vol. 31, pp. 535–561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. M. N. Rasband, J. Tayler, Y. Kaga et al., “CNP is required for maintenance of axon-glia interactions at nodes of ranvier in the CNS,” Glia, vol. 50, no. 1, pp. 86–90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S. N. Mitkus, T. M. Hyde, R. Vakkalanka et al., “Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia,” Schizophrenia Research, vol. 98, no. 1–3, pp. 129–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. F. M. Benes, “Relationship of cingulate cortex to schizophrenia and other psychiatric disorders,” in Neurobiology of Cingulate Cortex and Limbic Thalamus: A Comprehensive Handbook, B. A. Vogt and M. Gabriel, Eds., pp. 581–605, Birkhauser, Boston, Mass, USA, 1993. View at Google Scholar
  58. S. W. Flynn, D. J. Lang, A. L. Mackay et al., “Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins,” Molecular Psychiatry, vol. 8, no. 9, pp. 811–820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Hao, Q. Yan, H. Liu et al., “Schizophrenia patients and their healthy siblings share disruption of white matter integrity in the left prefrontal cortex and the hippocampus but not the anterior cingulate cortex,” Schizophrenia Research, vol. 114, no. 1–3, pp. 128–135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Bartzokis and L. Altshuler, “Reduced intracortical myelination in schizophrenia,” The American Journal of Psychiatry, vol. 162, no. 6, pp. 1229–1230, 2005. View at Google Scholar · View at Scopus
  61. A. MacKay, C. Laule, I. Vavasour, T. Bjarnason, S. Kolind, and B. Mädler, “Insights into brain microstructure from the T2 distribution,” Magnetic Resonance Imaging, vol. 24, no. 4, pp. 515–525, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Kyriakopoulos, R. Perez-Iglesias, J. B. Woolley et al., “Effect of age at onset of schizophrenia on white matter abnormalities,” The British Journal of Psychiatry, vol. 195, no. 4, pp. 346–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Reddy and M. S. Keshavan, “Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 69, no. 6, pp. 401–405, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Prabakaran, J. E. Swatton, M. M. Ryan et al., “Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress,” Molecular Psychiatry, vol. 9, no. 7, p. 643, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Schwarz, S. Prabakaran, P. Whitfield et al., “High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides,” Journal of Proteome Research, vol. 7, no. 10, pp. 4266–4277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Martins-de-Souza, W. F. Gattaz, A. Schmitt et al., “Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia,” Journal of Psychiatric Research, vol. 43, no. 11, pp. 978–986, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Tkachev, M. L. Mimmack, S. J. Huffaker, M. Ryan, and S. Bahn, “Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia,” International Journal of Neuropsychopharmacology, vol. 10, no. 4, pp. 557–563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Dracheva, S. A. Marras, S. L. Elhakem, F. R. Kramer, K. L. Davis, and V. Haroutunian, “N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia,” The American Journal of Psychiatry, vol. 158, no. 9, pp. 1400–1410, 2001. View at Publisher · View at Google Scholar · View at Scopus